Chemical inhibitors of 1190002F15Rik can exercise their inhibitory effects through various biochemical pathways. Bisindolylmaleimide I targets Protein Kinase C (PKC), which is crucial for the phosphorylation-based activation of 1190002F15Rik. By inhibiting PKC, Bisindolylmaleimide I effectively prevents the activation of 1190002F15Rik, leading to its functional inhibition. Similarly, H-89 inhibits Protein Kinase A (PKA), another kinase that phosphorylates and activates 1190002F15Rik, thereby exerting an inhibitory effect on the protein. ML-7 acts by inhibiting myosin light chain kinase (MLCK), which plays a role in the cytoskeletal rearrangements associated with 1190002F15Rik, resulting in a downstream inhibition of the protein's function. PD 169316 and SB 203580 both inhibit p38 MAP kinase, which is potentially involved in the regulation of 1190002F15Rik, especially under stress response conditions. The inhibition of this kinase can thus impede the activity of 1190002F15Rik.
LY 294002 and Wortmannin both exert their effects through the inhibition of PI3K, an upstream regulator of the Akt pathway, which is necessary for the modulation and activity of 1190002F15Rik. Inhibition of PI3K therefore results in reduced activity of 1190002F15Rik. U0126 targets MEK1/2, hindering the MAPK/ERK pathway, which is another potential upstream regulator of 1190002F15Rik. By blocking this pathway, U0126 can suppress the activity of 1190002F15Rik. PP2 inhibits Src family kinases, which may act upstream of 1190002F15Rik in signal transduction pathways, leading to its inhibition. SP600125 inhibits c-Jun N-terminal kinase (JNK), involved in signaling pathways that regulate 1190002F15Rik, thereby inhibiting the protein. Y-27632 inhibits Rho-associated protein kinase (ROCK), which is linked to actin cytoskeleton organization, a process in which 1190002F15Rik is potentially involved, and its inhibition can result in the functional inhibition of 1190002F15Rik. Lastly, Rapamycin inhibits mTOR, a central player in cell growth and proliferation, thereby possibly inhibiting the activity or function of 1190002F15Rik if it is involved in these cellular processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Inhibits Protein Kinase C (PKC) which is essential for the activation of 1190002F15Rik through phosphorylation. | ||||||
H-89 dihydrochloride | 130964-39-5 | sc-3537 sc-3537A | 1 mg 10 mg | $94.00 $186.00 | 71 | |
Inhibits Protein Kinase A (PKA) which is involved in the phosphorylation that activates 1190002F15Rik. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
Inhibits myosin light chain kinase (MLCK) which is involved in the cytoskeletal rearrangements that 1190002F15Rik is implicated in. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAP kinase which may regulate 1190002F15Rik as part of the cellular stress response. | ||||||
SB 202190 | 152121-30-7 | sc-202334 sc-202334A sc-202334B | 1 mg 5 mg 25 mg | $31.00 $128.00 $454.00 | 45 | |
Specifically inhibits p38 MAP kinase which could directly decrease the activity of 1190002F15Rik if it relies on p38 MAPK signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K which is upstream of the Akt pathway; necessary for the regulation of 1190002F15Rik. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibits MEK1/2, which would block the MAPK/ERK pathway and thus could inhibit the activity of 1190002F15Rik if it is downstream of this pathway. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Inhibits Src family kinases which could be upstream of 1190002F15Rik in signal transduction pathways. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits c-Jun N-terminal kinase (JNK) which is involved in the signaling pathways that regulate 1190002F15Rik. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Inhibits Rho-associated protein kinase (ROCK), potentially decreasing the activity of 1190002F15Rik associated with actin cytoskeleton organization. | ||||||